irblog.prnewswire.com

Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus

- Novel product provides qualified clinicians with the option of non-invasive retrograde flushing of the ventricular catheter, to unblock occluded inlet holes or open a relief membrane to restore or ...
BIOENGINEER

Ventricular injury timelines may not fit the heart’s conduction system

A critical review finds that immunohistochemical injury timelines established in ventricular muscle cannot yet be reliably ...

BioVentrix® Receives CPT® Category III Code for Surgical LV Restoration Using Epicardial Ventricular Anchoring System

Approval creates a dedicated reporting code for left ventricular restoration by plication Code 1132T approval marks a ...
Forbes

FDA Advisory Panel Gives Green Light To HeartWare Ventricular Assist System

The FDA's Circulatory System Devices panel voted 9-2 on Wednesday to recommend approval of the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage ...
Business Wire

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...
Yahoo Finance

FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT

Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely. SUNNYVALE, Calif., April 17, 2025 /PRNewswire/ -- EBR Systems, Inc. (ASX: EBR) has received ...
irblog.prnewswire.com

Anuncia Medical Inc. Announces Published Data with Promising Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts

SCOTTSDALE, Ariz., May 23, 2023 /PRNewswire/ -- Anuncia Medical Inc. ("Anuncia" or the "Company"), a company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF ...
The New England Journal of Medicine

Physiologic Pacing in Heart Failure

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
Yahoo Finance

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia

LAGUNA HILLS, Calif., May 21, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of ...
TCTMD

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
Medical Xpress

Pulsed field ablation system shows promise for reducing ventricular tachycardia recurrence

Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.